Association of cytokine gene polymorphisms with psoriasis in cases from the Nile Delta of Egypt

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 18, Issue 3, 2009, Pages 105-112

  Settin, Ahmad ^a,b   Hassan, Hanaa ^c   El Baz, Rizk ^a   Hassan, Tahia ^c  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^b QASSIM UNIVERSITY   (Saudi Arabia)

^c Mansoura University   (Egypt)

Author keywords

Cytokines; Gene polymorphism; Psoriasis

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EGYPT; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOSITY; HUMAN; MALE; POLYMERASE CHAIN REACTION; PSORIASIS; SEX DIFFERENCE; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; CYTOKINES; EGYPT; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSORIASIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 70350166548     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Naldi L. Epidemiology of psoriasis. Curr Drug Targets Inflamm Allergy. 2004 Jun;3(2):121-128
2. Sabat R, Philipp S, Höflich C, Kreutzer S, Wallace E, Asadullah K, Volk HD, Sterry W, Wolk K. Immunopathogenesis of psoriasis. Exp Dermatol. 2007 Oct;16(10):779-798
3. Chiarini A, Dal Pra I, Pacchiana R, Zumiani G, Zanoni M, Armato U. Comano's (Trentino) thermal water interferes with interleukin-6 production and secretion and with cytokeratin-16 expression by cultured human psoriatic keratinocytes: further potential mechanisms of its anti-psoriatic action. Int J Mol Med. 2006 Dec;18(6):1073-1079
4. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998 Oct 1;102(7):1369-1376 (Pubitemid 28467565)
5. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3725-3729
6. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765.
7. Kimball AB, Kawamura T, Tejura K, Boss C, Hancox AR, Vogel JC, Steinberg SM, Turner ML, Blauvelt A. Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10. Arch Dermatol. 2002 Oct;138(10):1341-1346
8. Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human ILIO gene and further characterization of the 5′ flanking sequence. Immunogenetics. 1997;46(2):120-128 (Pubitemid 27234709)
9. Ravindran JS, Owen P, Lagan A, Lewis J, Korendowych E, Welsh K, McHugh N. Interleukin 1alpha, interleukin 1beta and interleukin 1 receptor gene polymorphisms in psoriatic arthritis. Rheumatology (Oxford). 2004 Jan;43(1):22-26
10. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 1993 May;91(4):403-404
11. Haider AS, Cohen J, Fei J, Zaba LC, Cardinale I, Toyoko K, Ott J, Krueger JG. Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome. J Invest Dermatol. 2008 Mar;128(3):655-666 (Pubitemid 351252666)
12. Wastowski IJ, Peres NT, Simões RT, Castelli EC, Simões AL, Martinez-Rossi NM, Donadi EA. Identification of a novel 120 bp allele at the TNFd microsatellite locus. Tissue Antigens. 2006 Apr;67(4):318-320
13. Hajeer AH, Hutchinson IV. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol. 2001 Nov;62(11):1191-1199
14. Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res. 2007 Apr;48(4):751-762 Epub 2007 Jan 2. Review. (Pubitemid 46557880)
15. Gottlieb AB, Chaudhari U, Baker DG, Perate M, Dooley LT. The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison. J Drugs Dermatol. 2003;2:260-266
16. Sargen K, Demaine AG, Kingsnorth AN. Cytokine gene polymorphisms in acute pancreatitis. JOP. 2000 Jul;1(2):24-35.
17. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM. Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood. 1999 Dec 1;94(11):3941-3946
18. Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood. 2001 Sep 1;98(5):1594-1600
19. Wilkinson RJ, Patel P, Llewelyn M, Hirsch CS, Pasvol G, Snounou G, Davidson RN, Toossi Z. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med. 1999 Jun 21;189(12):1863-1874 (Pubitemid 29295885)
20. Burden AD, Javed S, Bailey M. Genetics of psoriasis: paternal inheritance and a locus on chromosome 6p. J Invest Dermatol. 1998 Jun;110(6):958-960 (Pubitemid 28237704)
21. Guenther LC, Ortonne JP. Pathophysiology of psoriasis: science behind therapy. J Cutan Med Surg. 2002 May-Jun;6(suppl 3):2-7.
22. Mehlis SL, Gordon KB. The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol. 2003 Aug;49(suppl 2):S44-50.
23. Turner DM; Williams DM, Sankaran D. An investigation of polymorphism in the interleukin-10 gene. Eur J Immunogenet. 1997 Feb;24(1):1-8.
24. Elkayam O, Yaron I, Shirazi I. Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis. Rheumatol Int. 2000;19(3):101-106 (Pubitemid 30189841)
25. Borska L, Andrys C, Krejsek J, Hamakova K, Kremlacek J, Ettler K, Fiala Z. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen. Int J Dermatol. 2008 Aug;47(8):800-805
26. Partsch G, Steiner G, Leeb BF, Dunky A, Broll H, Smolen JS. Highly increased levels of tumor necrosis factor-alpha and other proinflammatory cytokines in psoriatic arthritis synovial fluid. J Rheumatol. 1997;24:518-523 (Pubitemid 27153418)
27. Creaven PJ, Stoll HL. Response to tumour necrosis factor in two cases of psoriasis. J Am Acad Dermatol. 1991 May;24(5 Pt 1):735-741
28. Takematsu H, Ozawa H, Yoshimura T, Hara M, Sakakibara A, Oyama J, Tagami H. Systemic TNF administration in psoriatic patients: a promising therapeutic modality for severe psoriasis. Br J Dermatol. 1991 Feb;124(2):209-210
29. Nedoszytko B, Szczerkowska-Dobosz A, Zabłotna M, Glenł J, Rebala K, Roszkiewicz J. Associations of promoter region polymorphisms in the tumour necrosis factor-á gene and early-onset psoriasis vulgaris in a northern Polish population. Br J Dermatol. 2007 Jul;157(1):165-172 (Pubitemid 46934284)
30. Reich K, Westphal G, Schulz T. Combined analysis of polymorphisms of the tumor necrosis factor-a and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol. 1999;113:214-234 (Pubitemid 30202525)
31. Arias AI, Giles B, Eiermann TH, Sterry W, Pandey JP. Tumor necrosis factor-alpha gene polymorphism in psoriasis. Exp Clin. Immunogenet. 1997;14(2):118-140
32. Craven N, Jackson C, Kirby B. Cytokine gene polymorphis in psoriasis. Br J Dermatol. 2001 Apr;144(4):849-902.
33. Al-Heresh AM, Proctor J, Jones SM, Dixey J, Cox B, Welsh K, McHugh N. Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. Rheumatology (Oxford). 2002 May;41(5):525-30.
34. Baran W, Szepietowski JC, Mazur G, Baran E. A -308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris. No difference either between psoriasis type I and type II patients. Acta Dermatovenerol Alp Pannonica Adriat. 2006 Sep;15(3):113-118
35. Mallon E, Bunce M, Savoie H, Rowe A, Newson R, Gotch F, Bunker CB. HLA-C and guttate psoriasis. Br J Dermatol. 2000 Dec;143(6):1177-1182
36. Kingo K, Koks S, Silm H, Vasar E. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes Immun. 2003 Sep;4(6):455-461
37. Höhler T, Kruger A, Schneider PM, Schopf RE, Knop J, Rittner C, Meyer zum Büschenfelde KH, Märker-Hermann E. A TNF-alpha promoter polymorphism is associated with juvenile onset psoriasis and psoriatic arthritis. J Invest Dermatol. 1997 Oct;109(4):562-565
38. Chang YT, Chou CT, Yu CW, Lin MW, Shiao YM, Chen CC, Huang CH, Lee DD, Liu HN, Wang WJ, Tsai SF. Cytokine gene polymorphisms in Chinese patients with psoriasis. Br J Dermatol. 2007 May;156(5):899-905. (Pubitemid 46642859)
39. Baran W, Szepietowski JC, Mazur G, Baran E. IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris. Acta Derm Venereol. 2008;88(2):113-116
40. Clay FE, Cork MJ, Tarlow JK. Interleukin-1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet. 1994; 94: 407-410 (Pubitemid 24297728)
41. Mansfield JC, Holden H, Tarlow JK. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterol. 1994 Jul;43(1):33-42.
42. Peddle L, Butt C, Snelgrove T, Rahman P. Interleukin (IL) 1alpha, IL1beta, IL receptor antagonist, and IL10 polymorphisms in psoriatic arthritis. Ann Rheum Dis. 2005 Jul;64(7):1093-1094